We are live on ! Find out more
NVAX icon

Novavax

81 hedge funds and large institutions have $35.7M invested in Novavax in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

210% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 10

166% more call options, than puts

Call options by funds: $13.6M | Put options by funds: $5.12M

0.88% more ownership

Funds ownership: 28.74%29.62% (+0.88%)

0% more funds holding

Funds holding: 8181 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

10% less capital invested

Capital invested by funds: $39.7M → $35.7M (-$3.95M)

Holders
81
Holders Change
Holders Change %
0%
% of All Funds
1.78%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
31
Reduced
10
Closed
11
Calls
$13.6M
Puts
$5.12M
Net Calls
+$8.51M
Net Calls Change
-$6.3M

NVAX Hedge Fund Activity: Q3 2019 in Review

81 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2019, worth a combined $35.7M — down 10% from $39.7M a quarter earlier.

Fund positioning in NVAX was balanced in Q3 2019: 11 funds opened new positions, 11 closed out, 31 added to existing stakes and 10 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $1.51M. The largest seller was Morgan Stanley, cutting an estimated $877K.

  • 81 institutional investors held Novavax (NVAX) as of Q3 2019, unchanged from Q2 2019.
  • Funds reported $35.7M of Novavax stock for Q3 2019, down 10% quarter-over-quarter.
  • 11 funds opened new Novavax positions in Q3 2019 and 11 closed out, a net change of 0 holders.
  • The largest Novavax buyer in Q3 2019 was JP Morgan Chase, an estimated $1.51M added.
  • The largest Novavax seller in Q3 2019 was Morgan Stanley, an estimated $877K sold.

Based on aggregated 13F filings for Q3 2019.